InconclusiveReview/Other2025
The endocannabinoid system offers a target for Alzheimer's disease treatment through inhibition of fatty acid amide hydrolase (<scp>FAAH</scp>)
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/A